Champions Oncology (CSBR) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart Transcripts

Champions Oncology Revenue Highlights

Main Segment (Y)

Pharmacology Services

Champions Oncology Revenue by Period

Champions Oncology Revenue by Year

Date	Revenue	Change
2024-04-30	-	-100.00%
2023-04-30	$53.87M	9.69%
2022-04-30	$49.11M	19.66%
2021-04-30	$41.04M	27.76%
2020-04-30	$32.12M	18.68%
2019-04-30	$27.07M	33.72%
2018-04-30	$20.24M	31.34%
2017-04-30	$15.41M	37.82%
2016-04-30	$11.18M	26.16%
2015-04-30	$8.86M	-23.26%
2014-04-30	$11.55M	39.75%
2013-04-30	$8.27M	15.61%
2012-04-30	$7.15M	3.88%
2011-04-30	$6.88M	40.65%
2010-04-30	$4.89M	31.89%
2009-04-30	$3.71M	165.01%
2008-04-30	$1.40M	100.00%
2007-04-30	-	100.00%
2006-04-30	-	-100.00%
2005-04-30	$1.80M	-10.10%
2004-04-30	$2.00M	-0.36%
2003-04-30	$2.01M	-5.72%
2002-04-30	$2.13M	-3.72%
2001-04-30	$2.21M	1.55%
2000-04-30	$2.18M	-1.06%
1999-04-30	$2.20M	-5.58%
1998-04-30	$2.33M	7.87%
1997-04-30	$2.16M	0.93%
1996-04-30	$2.14M	-

Champions Oncology generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Champions Oncology Revenue by Quarter

Date	Revenue	Change
2024-07-31	-	-100.00%
2024-04-30	$14.00M	16.49%
2024-01-31	$12.02M	3.85%
2023-10-31	$11.57M	-7.87%
2023-07-31	$12.56M	-3.90%
2023-04-30	$13.07M	2.33%
2023-01-31	$12.77M	-10.56%
2022-10-31	$14.28M	3.90%
2022-07-31	$13.74M	6.74%
2022-04-30	$12.88M	-2.40%
2022-01-31	$13.19M	11.94%
2021-10-31	$11.79M	4.74%
2021-07-31	$11.25M	6.51%
2021-04-30	$10.56M	-2.28%
2021-01-31	$10.81M	6.87%
2020-10-31	$10.12M	5.97%
2020-07-31	$9.55M	9.11%
2020-04-30	$8.75M	-2.91%
2020-01-31	$9.01M	18.19%
2019-10-31	$7.63M	13.18%
2019-07-31	$6.74M	-12.71%
2019-04-30	$7.72M	20.03%
2019-01-31	$6.43M	-3.93%
2018-10-31	$6.69M	7.52%
2018-07-31	$6.22M	26.47%
2018-04-30	$4.92M	-3.15%
2018-01-31	$5.08M	-2.33%
2017-10-31	$5.20M	3.38%
2017-07-31	$5.03M	35.30%
2017-04-30	$3.72M	4.35%
2017-01-31	$3.56M	-20.01%
2016-10-31	$4.46M	21.44%
2016-07-31	$3.67M	29.36%
2016-04-30	$2.84M	11.17%
2016-01-31	$2.55M	-14.10%
2015-10-31	$2.97M	5.28%
2015-07-31	$2.82M	-12.93%
2015-04-30	$3.24M	77.20%
2015-01-31	$1.83M	-2.82%
2014-10-31	$1.88M	-1.57%
2014-07-31	$1.91M	-22.21%
2014-04-30	$2.46M	-33.39%
2014-01-31	$3.69M	54.85%
2013-10-31	$2.38M	-21.09%
2013-07-31	$3.02M	63.95%
2013-04-30	$1.84M	-36.85%
2013-01-31	$2.92M	100.07%
2012-10-31	$1.46M	-30.77%
2012-07-31	$2.11M	52.50%
2012-04-30	$1.38M	-42.36%
2012-01-31	$2.40M	37.62%
2011-10-31	$1.74M	6.55%
2011-07-31	$1.63M	5.83%
2011-04-30	$1.54M	-44.96%
2011-01-31	$2.81M	200.64%
2010-10-31	$933.00K	-41.69%
2010-07-31	$1.60M	-15.79%
2010-04-30	$1.90M	156.06%
2010-01-31	$742.00K	-42.44%
2009-10-31	$1.29M	33.99%
2009-07-31	$962.00K	2.28%
2009-04-30	$940.54K	-10.61%
2009-01-31	$1.05M	0.77%
2008-10-31	$1.04M	55.12%
2008-07-31	$673.12K	199.16%
2008-04-30	$225.00K	-75.67%
2008-01-31	$924.94K	-

Champions Oncology generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Champions Oncology Revenue Breakdown

Champions Oncology Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Apr 24	Apr 23	Apr 22	Apr 21	Apr 20
Pharmacology Services	$47.03M	$50.71M	$46.83M	$39.47M	$31.26M
Personalized Oncology Services	$18.00K	$116.00K	$49.00K	$166.00K	$790.00K
Product and Service, Other	$3.10M	-	-	-	-
Other Services	-	$3.05M	$2.23M	$1.40M	$71.00K

Champions Oncology's latest annual revenue breakdown by segment (product or service), as of Apr 24: Pharmacology Services (93.78%), Product and Service, Other (6.18%), and Personalized Oncology Services (0.04%).

Quarterly Revenue by Product

Product/Service	Jul 24	Apr 24	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20	Oct 19
Pharmacology Services	$13.07M	$13.12M	$11.18M	$10.88M	$11.86M	$12.35M	$12.12M	$13.48M	$12.76M	$12.37M	$12.62M	$11.14M	$10.70M	$9.27M	$10.74M	$10.04M	$9.41M	$8.53M	$8.84M	$7.36M
Product and Service, Other	$992.00K	$886.00K	$835.00K	$697.00K	$684.00K	$648.00K	$731.00K	$948.00K	$546.00K	$643.00K	$526.00K	$62.00K	$39.00K	$21.00K	-	$35.00K	-	-	-	-
Personalized Oncology Services	-	$1.00K	-	-	$17.00K	-	$6.00K	$70.00K	$41.00K	-	$25.00K	-	$24.00K	$11.00K	$5.00K	$37.00K	$113.00K	$209.00K	$169.00K	$232.00K

Champions Oncology's latest quarterly revenue breakdown by segment (product or service), as of Jul 24: Pharmacology Services (92.95%), and Product and Service, Other (7.05%).

Champions Oncology Revenue Breakdown by Country

Quarterly Revenue by Country

Country	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20	Oct 19	Jul 19	Jan 19	Oct 18	Jul 18
Pharmacology Services	$12.35M	$12.12M	$13.48M	$12.76M	$12.37M	$12.62M	$11.14M	$10.70M	$9.27M	$10.74M	$10.04M	$9.41M	$8.53M	$8.84M	$7.36M	$6.53M	$5.99M	$6.24M	$5.78M
Personalized Oncology Services	-	$6.00K	$70.00K	$41.00K	-	$25.00K	-	$24.00K	$11.00K	$5.00K	$37.00K	$113.00K	$209.00K	$169.00K	$232.00K	$180.00K	$416.00K	$249.00K	$359.00K
Product and Service, Other	-	$648.00K	$731.00K	$948.00K	$546.00K	$643.00K	$526.00K	$62.00K	$39.00K	$21.00K	-	$35.00K	$27.00K	$26.00K	$208.00K	$89.00K	-	-	-

Champions Oncology's latest quarterly revenue breakdown by geography, as of Apr 23: Pharmacology Services (100.00%).

Champions Oncology Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ADAG	Adagene	$18.11M	$833.34K
MOLN	Molecular Partners	$7.04M	$2.74M
HCWB	HCW Biologics	$2.84M	$426.42K
IPSC	Century Therapeutics	$2.23M	$791.00K
STTK	Shattuck Labs	$1.66M	$1.61M
MNOV	MediciNova	$1.00M	-
ANEB	Anebulo Pharmaceuticals	-	-
RZLT	Rezolute	-	-
ANTX	AN2 Therapeutics	-	-
AVTE	Aerovate Therapeutics	-	-
CYT	Cyteir Therapeutics	-	-
ELYM	Eliem Therapeutics	-	-
ACRV	Acrivon Therapeutics	-	-
PRDS	Pardes Biosciences	-	-
CSBR	Champions Oncology	-	-

CSBR Revenue FAQ

What is Champions Oncology’s yearly revenue?

Champions Oncology's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $53.87M, representing an increase of 9.69% compared to 2022. CSBR's yearly revenue for 2022 was $49.11M, representing an increase of 19.66% compared to 2021.

What is Champions Oncology’s quarterly revenue?

Champions Oncology's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $14M, a 16.49% increase from the previous quarter (Q3 2024), and a 7.11% increase year-over-year (Q4 2023). CSBR's quarterly revenue for Q3 2024 was $12.02M, a 3.85% increase from the previous quarter (Q2 2024), and a -5.90% decrease year-over-year (Q3 2023).

What is Champions Oncology’s revenue growth rate?

Champions Oncology's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Champions Oncology’s revenue streams?

Champions Oncology's revenue streams in r 24 are Pharmacology Services, Personalized Oncology Services, and Product and Service, Other. Pharmacology Services generated $47.04M in revenue, accounting 93.78% of the company's total revenue, down -7.24% year-over-year. Personalized Oncology Services generated $18K in revenue, accounting 0.04% of the company's total revenue, down -84.48% year-over-year. Product and Service, Other generated $3.1M in revenue, accounting 6.18% of the company's total revenue

What is Champions Oncology’s main source of revenue?

For the fiscal year ending Apr 24, the largest source of revenue of Champions Oncology was Pharmacology Services. This segment made a revenue of $47.04M, representing 93.78% of the company's total revenue.